Oral Chemotherapy and Quality of Care
NCT03561467 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2018-06-19
Summary
PARCOURS is a non-interventional research study evaluating dysfunctions in the continuous city-hospital journey of a patients cohort treated by oral chemotherapy (60 patients followed for 3 months).
References used are the National Cancer Institute recommendations for the oral chemotherapy treated outpatients.
Parameters found are : information exchanged, ambulatory and hospital monitoring in case of adverse event and adherence to treatment. The study includes also a medico-economic evaluation (hospitalization and transport spending in case of dysfunction in the patient's journey). Deviations will be analyzed.
Conditions
Interventions
- OTHER
-
Observational
Evaluation of dysfunctions in the continuous city-hospital journey of a patients cohort treated by oral chemotherapy
Sponsors & Collaborators
-
MSD France
collaborator INDUSTRY -
University Hospital, Caen
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-29
- Primary Completion
- 2018-06-29
- Completion
- 2018-09-29
Countries
- France
Study Locations
More Related Trials
-
Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer
NCT00209664 ·Status: SUSPENDED ·Phase: PHASE2
-
The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer
NCT01787539 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer
NCT01851941 ·Status: COMPLETED ·Phase: PHASE2
-
Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer
NCT01876927 ·Status: COMPLETED ·Phase: PHASE2
-
NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma
NCT02486601 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric Carcinoma
NCT02024217 ·Status: UNKNOWN ·Phase: PHASE2
-
The Therapeutic Effect of Different Doses of Capecitabine
NCT06246461 ·Status: COMPLETED ·Phase: NA
-
Study of Weekly DCF to Treat Advanced Gastric Cancer
NCT00568971 ·Status: TERMINATED ·Phase: PHASE2
-
Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer
NCT00209638 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis
NCT00149201 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
NCT02114359 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions
NCT06313801 ·Status: RECRUITING ·Phase: PHASE2
-
Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib As Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma
NCT05268510 ·Status: COMPLETED ·Phase: PHASE2
-
Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer
NCT00420394 ·Status: UNKNOWN ·Phase: PHASE2
-
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
NCT01053390 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer
NCT00290966 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer
NCT00587145 ·Status: UNKNOWN ·Phase: PHASE2
-
Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2)
NCT00147147 ·Status: COMPLETED ·Phase: PHASE3
-
Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS
NCT01917552 ·Status: RECRUITING ·Phase: PHASE3
-
Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer
NCT00980603 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer
NCT00591045 ·Status: UNKNOWN ·Phase: PHASE2
-
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors
NCT01040312 ·Status: COMPLETED
-
Metastatic Gastric Cancer FFCD 03-07
NCT00374036 ·Status: COMPLETED ·Phase: PHASE3
-
Neoadjuvant Combination Chemotherapy of DCS and DCF in Patients With Locally Advanced Gastric Adenocarcinoma
NCT01286766 ·Status: COMPLETED ·Phase: PHASE2
-
Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer
NCT01756183 ·Status: UNKNOWN ·Phase: PHASE2